Compare Stocks: ANIK, LMAT, and KIDS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANIK Anika Therapeutics	$21.39 -0.1%	$20.65	$9.01 ▼ $22.88	$286.20M	0.21	112,510 shs	18,393 shs
KIDS OrthoPediatrics	$23.94 -2.3%	$23.01	$14.42 ▼ $26.74	$624.94M	0.99	178,932 shs	57,404 shs
LMAT LeMaitre Vascular	$84.81 +0.4%	$81.08	$78.22 ▼ $118.01	$1.94B	0.48	274,830 shs	44,948 shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANIK Anika Therapeutics	0.00%	+7.21%	+5.15%	+42.61%	+113.99%
KIDS OrthoPediatrics	0.00%	+11.62%	+8.65%	+23.61%	+43.86%
LMAT LeMaitre Vascular	0.00%	+4.49%	+3.59%	-14.64%	-5.34%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANIK Anika Therapeutics	$21.39 -0.1%	$20.65	$9.01 ▼ $22.88	$286.20M	0.21	112,510 shs	18,393 shs
KIDS OrthoPediatrics	$23.94 -2.3%	$23.01	$14.42 ▼ $26.74	$624.94M	0.99	178,932 shs	57,404 shs
LMAT LeMaitre Vascular	$84.81 +0.4%	$81.08	$78.22 ▼ $118.01	$1.94B	0.48	274,830 shs	44,948 shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANIK Anika Therapeutics	0.00%	+7.21%	+5.15%	+42.61%	+113.99%
KIDS OrthoPediatrics	0.00%	+11.62%	+8.65%	+23.61%	+43.86%
LMAT LeMaitre Vascular	0.00%	+4.49%	+3.59%	-14.64%	-5.34%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ANIK Anika Therapeutics	2.25	Hold	$22.00	2.85% Upside
KIDS OrthoPediatrics	2.57	Moderate Buy	$26.50	10.72% Upside
LMAT LeMaitre Vascular	2.33	Hold	$110.60	30.41% Upside

Current Analyst Ratings Breakdown

Latest ANIK, LMAT, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/23/2026	LMAT LeMaitre Vascular	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
10/8/2026	LMAT LeMaitre Vascular	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
10/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
9/28/2026	ANIK Anika Therapeutics	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
9/21/2026	ANIK Anika Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/18/2026	ANIK Anika Therapeutics	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$21.00 ➝ $23.00
9/14/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$29.00
8/20/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$24.00 ➝ $29.00
8/14/2026	LMAT LeMaitre Vascular	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
8/5/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/5/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$22.00

(Data available from 10/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ANIK Anika Therapeutics	$112.82M	2.54	N/A	N/A	$9.95 per share	2.15
KIDS OrthoPediatrics	$236.35M	2.64	$0.16 per share	147.34	$13.82 per share	1.73
LMAT LeMaitre Vascular	$249.60M	7.77	$2.91 per share	29.10	$17.35 per share	4.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ANIK Anika Therapeutics	-$10.88M	-$0.27	N/A	73.76	15.30	-3.14%	0.20%	0.15%	11/6/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-15.72%	-8.10%	-5.54%	10/27/2026 (Estimated)
LMAT LeMaitre Vascular	$57.73M	$2.85	29.76	26.67	2.44	25.02%	15.63%	10.06%	11/4/2026 (Estimated)

Latest ANIK, LMAT, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/6/2026	Q3 2026	ANIK Anika Therapeutics	$0.42	N/A	N/A	N/A	$29.44 million	N/A
11/4/2026	Q3 2026	LMAT LeMaitre Vascular	$0.6860	N/A	N/A	N/A	$67.39 million	N/A
10/27/2026	Q3 2026	KIDS OrthoPediatrics	-$0.2250	N/A	N/A	N/A	$68.50 million	N/A
8/4/2026	Q2 2026	KIDS OrthoPediatrics	-$0.3022	-$0.26	+$0.0422	-$0.30	$68.21 million	$70.51 million
8/4/2026	Q2 2026	LMAT LeMaitre Vascular	$0.8070	$0.74	-$0.0670	$0.74	$71.47 million	$70.38 million
7/29/2026	Q2 2026	ANIK Anika Therapeutics	$0.03	$0.42	+$0.39	$0.24	$29.21 million	$32.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ANIK Anika Therapeutics	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$1.00	1.18%	+16.05%	35.09%	14 Years

Latest ANIK, LMAT, and KIDS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/28/2026	LMAT LeMaitre Vascular	quarterly	$0.25	1.21%	8/20/2026	8/20/2026	9/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ANIK Anika Therapeutics	N/A	4.48	3.19
KIDS OrthoPediatrics	0.28	4.78	2.17
LMAT LeMaitre Vascular	0.40	16.31	13.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ANIK Anika Therapeutics	91.53%
KIDS OrthoPediatrics	69.05%
LMAT LeMaitre Vascular	84.64%

Insider Ownership

Company	Insider Ownership
ANIK Anika Therapeutics	12.08%
KIDS OrthoPediatrics	32.50%
LMAT LeMaitre Vascular	7.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ANIK Anika Therapeutics	235	13.38 million	11.77 million	Optionable
KIDS OrthoPediatrics	602	26.11 million	17.62 million	Optionable
LMAT LeMaitre Vascular	655	22.87 million	21.18 million	Optionable

ANIK, LMAT, and KIDS Headlines

Recent News About These Companies

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Has Consensus Price Target of $110.60 According to Analysts

October 20, 2026 | americanbankingnews.com

LeMaitre Vascular stock reports on November 4, 2026

October 19, 2026 | ad-hoc-news.deA

Annex Advisory Services LLC Sells 226,849 Shares of LeMaitre Vascular, Inc. $LMAT

October 18, 2026 | marketbeat.com

LeMaitre Vascular, Inc. Announces Retirement of David B. Roberts as President, Effective December 31, 2026

October 17, 2026 | marketscreener.comM

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Rated "Hold" by Sell-Side Analysts

October 15, 2026 | marketbeat.com

LeMaitre Vascular, Inc. $LMAT Stock Bought by Copeland Capital Management LLC

October 14, 2026 | marketbeat.com

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 29% Potential Upside

October 13, 2026 | directorstalkinterviews.com

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

October 12, 2026 | globenewswire.com

LeMaitre Vascular stock costs EUR 70.50 before November results

October 8, 2026 | ad-hoc-news.deA

Barrington Sticks to Its Buy Rating for Lemaitre Vascular (LMAT)

October 3, 2026 | theglobeandmail.com

LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine

October 1, 2026 | seekingalpha.com

LeMaitre Vascular stock faces a 0.74 EPS miss in Q2

September 29, 2026 | ad-hoc-news.deA

140,936 Shares of LeMaitre Vascular, Inc. $LMAT Purchased by Bank of America Corp DE

September 26, 2026 | marketbeat.com

Is LeMaitre Vascular (LMAT) A Bargain Following Its 90 Day Pullback?

September 25, 2026 | finance.yahoo.com

LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run

September 24, 2026 | finance.yahoo.com

LeMaitre Vascular Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is Exposed

September 23, 2026 | prnewswire.com

2 profitable stocks to target this week and 1 we ignore

September 21, 2026 | msn.com

2 profitable stocks to target this week and 1 we ignore

September 21, 2026 | msn.com

PAHC or LMAT: Which Is the Better Value Stock Right Now?

September 2, 2026 | zacks.com

LeMaitre Vascular stock weighed down despite institutional buying

September 1, 2026 | ad-hoc-news.deA

LeMaitre to Participate at Upcoming Investor Conferences in September

August 27, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANIK, LMAT, and KIDS Company Descriptions

Anika Therapeutics NASDAQ:ANIK

$21.39 -0.03 (-0.14%)

As of 12:06 PM Eastern

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$23.94 -0.57 (-2.31%)

As of 12:07 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

LeMaitre Vascular NASDAQ:LMAT

$84.81 +0.36 (+0.43%)

As of 12:07 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ANIK, LMAT, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ANIK, LMAT, and KIDS Earnings

Compare Dividends

Latest ANIK, LMAT, and KIDS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ANIK, LMAT, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANIK, LMAT, and KIDS Company Descriptions

Anika Therapeutics NASDAQ:ANIK

OrthoPediatrics NASDAQ:KIDS

LeMaitre Vascular NASDAQ:LMAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ANIK, LMAT, and KIDS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ANIK, LMAT, and KIDS Earnings

Compare Dividends

Latest ANIK, LMAT, and KIDS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ANIK, LMAT, and KIDS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANIK, LMAT, and KIDS Company Descriptions

Anika Therapeutics NASDAQ:ANIK

OrthoPediatrics NASDAQ:KIDS

LeMaitre Vascular NASDAQ:LMAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools